Streetbeat News

Analyst Ratings

MCK

Leerink Partners analyst Michael Cherny initiates coverage on McKesson (NYSE:MCK) with an Outperform rating and a price target of $600.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 1:46 pm

POOL

Oppenheimer analyst Scott Schneeberger maintains an Outperform rating on Pool Corporation (NASDAQ:POOL) and raises the price target from $370 to $407.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 1:45 pm

MAIN

Oppenheimer analyst Mitchel Penn maintains a Perform rating on Main Street Capital (MAIN) and raises the price target from $41 to $43.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 1:44 pm

HIMS

Leerink Partners analyst Michael Cherny initiates coverage on Hims & Hers Health (HIMS) with a Market Perform rating and a price target of $10.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 1:43 pm

WBA

Leerink Partners analyst Michael Cherny initiates coverage on Walgreens Boots Alliance (WBA) with a Market Perform rating and a price target of $23.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 1:42 pm

IONS

Oppenheimer analyst Justin Kim reinstates Ionis Pharmaceuticals (NASDAQ:IONS) with an Outperform rating and raises the price target from $63 to $65.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 1:40 pm

GDRX

Leerink Partners analyst Michael Cherny initiates coverage on GoodRx Holdings (NASDAQ:GDRX) with an Outperform rating and a price target of $8.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 1:40 pm

DOCS

Leerink Partners analyst Michael Cherny initiates coverage on Doximity (NYSE:DOCS) with a Market Perform rating and a price target of $32.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 1:38 pm

SM

Susquehanna analyst Biju Perincheril maintains a Neutral rating on SM Energy (NYSE:SM) and raises the price target from $38 to $42.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 1:38 pm

CERT

Leerink Partners analyst Michael Cherny initiates coverage on Certara (NASDAQ:CERT) with a Market Perform rating and a price target of $19.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 1:36 pm